Cutler Group’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$28K Buy
+350
New +$15.6K 0.01% 902
2023
Q4
Sell
-2,495
Closed -$32.6K 4671
2023
Q3
$27K Sell
2,495
-2,211
-47% -$31.6K ﹤0.01% 1840
2023
Q2
$76K Buy
4,706
+1,611
+52% +$33.8K 0.02% 1067
2023
Q1
$51K Sell
3,095
-2,005
-39% -$20.7K 0.01% 1344
2022
Q4
$47K Sell
5,100
-3,334
-40% -$14.9K 0.01% 1614
2022
Q3
$22K Hold
8,434
﹤0.01% 2561
2022
Q2
$24K Sell
8,434
-900
-10% -$2.23K ﹤0.01% 2536
2022
Q1
$28K Buy
+9,334
New +$33.5K ﹤0.01% 2770
2020
Q2
Sell
-19,300
Closed -$90K 5316
2020
Q1
$90K Buy
19,300
+14,300
+286% +$87.9K 0.01% 1383
2019
Q4
$40K Sell
5,000
-3,000
-38% -$21.9K ﹤0.01% 1782
2019
Q3
$55K Hold
8,000
0.01% 1469
2019
Q2
$66K Hold
8,000
0.01% 1351
2019
Q1
$79K Sell
8,000
-4,200
-34% -$35.2K 0.01% 1143
2018
Q4
$93K Sell
12,200
-10,730
-47% -$128K 0.01% 1075
2018
Q3
$399K Buy
22,930
+9,060
+65% +$108K 0.04% 558
2018
Q2
$131K Buy
+13,870
New +$92.3K 0.01% 986

Other funds holding VKTX